4th Quarter - Report

MCKESSON CORPORATION & ITS AFFILIATE U.S. ONCOLOGY for MCKESSON CORPORATION & ITS AFFILIATE U.S. ONCOLOGY

Firm
Client
Income
—
Expenses
$280,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

S. 1221, To amend title XVIII of the Social Security Act H.R. 1392, To amend title XVIII of the Social Security Act

LobbyistCovered position, as disclosed
ANN RICHARDSON BERKEY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Bills named: S. 1221 (111th), H.R. 1392 (111th)

Pharmacy PHA

Meetings/education regarding pharmacy issues.

LobbyistCovered position, as disclosed
ANN RICHARDSON BERKEY —

Contacted: SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Taxation/Internal Revenue Code TAX

Legislation regarding potential LIFO issue.

LobbyistCovered position, as disclosed
ANN RICHARDSON BERKEY —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Meetings/education regarding health care reform implementation and related issues.

LobbyistCovered position, as disclosed
ANN RICHARDSON BERKEY —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Veterans VET

Education regarding the Department of Veterans Affairs Pharmaceutical Prime Vendor contract.

LobbyistCovered position, as disclosed
ANN RICHARDSON BERKEY —

Contacted: Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.